A recently discovered cellular weight enzyme may be a target for the treatment of neurodegenerative disease
An enzyme called MARK2 was identified as a major stress response mutation in cells in a study by researchers at the Johns Hopkins Bloomberg School of Public Health. Abstinence of this type of stres…
